<DOC>
	<DOC>NCT01889745</DOC>
	<brief_summary>This study is designed to multiple dose and dose escalation study</brief_summary>
	<brief_title>A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.</brief_title>
	<detailed_description>A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Single Dose Escalation Study of the Safety, Tolerabiluty, and Pharmacokinetics of HX-1171 in Healthy Male Subjects</detailed_description>
	<criteria>Adult males aged 20 to 40 years at screening. Be able to comply with the requirement of the study. Subject must provide written informed consent prior to study participation. History or presence of liver, kidney, or nervous system disease, respiratory disorders, endocrinological disorders, hematooncologic, cardiovascular or psychiatric or gastrointestinal disorders. History of known hypersensitivity to drugs including HX1171.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>